Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The NAD Dependent Deacetylase Activity of Sirtuin1 in COVID19 Patients

NCT04907916 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04907916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The NAD Dependent Deacetylase Activity of Sirtuin1 in COVID19 Patients
Lead sponsor
Assiut University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2021
Completion date
January 1, 2023
Enrollment
130 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

covid19